2006
DOI: 10.1074/jbc.m600456200
|View full text |Cite
|
Sign up to set email alerts
|

Histone Deacetylase Inhibitors Repress the Transactivation Potential of Hypoxia-inducible Factors Independently of Direct Acetylation of HIF-α

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
124
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 103 publications
(126 citation statements)
references
References 71 publications
2
124
0
Order By: Relevance
“…Recent studies have established that HDAC inhibitors decrease HIF activation in tumor cell lines (Kim et al, 2001(Kim et al, , 2007Fath et al, 2006;Kong et al, 2006;Qian et al, 2006), although the mechanism(s) by which HDAC modulate HIF activity remains controversial (Bilton et al, 2006). Our experiments demonstrate that sodium butyrate, an HDAC inhibitor in clinical use (Davie, 2003), improves epithelial-like cell shape and TJ assembly in VHL-defective RCC4 and RCC10 cells and increases expression of E-cadherin, occludin, and claudin 1.…”
Section: Discussionmentioning
confidence: 50%
“…Recent studies have established that HDAC inhibitors decrease HIF activation in tumor cell lines (Kim et al, 2001(Kim et al, , 2007Fath et al, 2006;Kong et al, 2006;Qian et al, 2006), although the mechanism(s) by which HDAC modulate HIF activity remains controversial (Bilton et al, 2006). Our experiments demonstrate that sodium butyrate, an HDAC inhibitor in clinical use (Davie, 2003), improves epithelial-like cell shape and TJ assembly in VHL-defective RCC4 and RCC10 cells and increases expression of E-cadherin, occludin, and claudin 1.…”
Section: Discussionmentioning
confidence: 50%
“…Instead, diverse other mechanisms have been proposed for the HDAC inhibitor-induced HIF-1 regulation; Kong et al (2006) showed that HDAC inhibitors induced the proteasomal degradation of HIF-1a by interacting with HSP70 and thereby disrupted the HSP70/HSP90 axis function. In the other hand, Fath et al (2006) reported that acetylation regulated HIF-1 function by targeting the HIF-1a/p300 complex, not by directly targeting HIF-1a. Here, we showed that the ODD domain of HIF-1a was deacetylated in the presence of HBx (Figure 4), and the deacetylation was accompanied by further process of proteasomal degradation, such as binding to PHDs and VHL ( Figure 5).…”
Section: Discussionmentioning
confidence: 99%
“…8 This has been demonstrated further in a study by Fath et al showing that HDAC inhibitors repress the transactivation potential of HIF-1α under hypoxic conditions by targeting the HIF-1α/p300 complex. 9 Other members of the HIF-1α coactivation complex SRC-1 and TIF2 have also been found to have histone acetyltransferase activity which enhance the hypoxia-inducible activity of HIF-1α both independently and in synergy with CBP/p300. 10 Histone deacetylase enzymes such as HDAC1, 3 and 7 have also been implicated in the actions of HIF-1α.…”
mentioning
confidence: 99%